Shariah compliance overview
Not HalalEditas Medicine, Inc. (EDIT) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Editas Medicine, Inc.
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology.
Editas Medicine, Inc. (EDIT) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 25.81%Limit 5%Fail
- Interest-bearing debt
- 18.33%Limit 30%Pass
- Interest-bearing securities and assets
- 41.59%Limit 30%Fail
- Dividend purification
- 25.81%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Editas Medicine, Inc. (EDIT). Current Akinda screening label: Not Halal.
